AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

06 Mar 2024 15:32:07 By Nasdaq GlobeNewswire

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

06 Mar 2024 15:31:28 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

07 Dec 2023 15:05:38 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

30 Nov 2023 15:05:57 By Nasdaq GlobeNewswire

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

08 Nov 2023 07:05:03 By Nasdaq GlobeNewswire

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

17 Oct 2023 07:05:09 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

26 Sep 2023 15:05:51 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

07 Sep 2023 15:05:25 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023

31 Aug 2023 15:05:10 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023

21 Jun 2023 15:07:37 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023

14 Jun 2023 15:05:54 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

10 May 2023 15:05:31 By Nasdaq GlobeNewswire

Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

04 Apr 2023 07:05:38 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

13 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023

06 Mar 2023 15:05:56 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments

06 Dec 2022 15:05:00 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022

29 Nov 2022 15:05:00 By Nasdaq GlobeNewswire

Avid Bioservices Appoints Oksana Lukash as Vice President, People

16 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

02 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Global CDMO Conference

27 Sep 2022 15:05:00 By Nasdaq GlobeNewswire